CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10640805 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature